文献速递神经肿瘤

美国胶质母细胞瘤患者在高容量癌症委员会认证医院接受手术的机会差异

Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States.
PubMed 文献 · J Neurosurg · 2021-11-12

该研究基于国家癌症数据库2004—2015年新诊断胶质母细胞瘤患者,分析在高容量医院(年手术量≥90百分位)接受手术的种族与社会经济差异。共纳入51,859例,10.7%在高容量医院手术;西班牙裔白人、农村居民、非私人保险及低收入患者在高容量医院手术的比值显著更低。亚组分析提示2004至2016年间部分种族与社会经济差异可能扩大。

要点

  • 西班牙裔白人患者在高容量医院手术的比值显著低于非西班牙裔白人(OR 0.58)。
  • 农村居民、非私人保险及低收入患者在高容量医院手术的比值显著更低。
  • 部分弱势亚组2004至2016年间在高容量医院手术的比值无显著变化。

核心结论

  • 美国胶质母细胞瘤患者在高容量医院接受手术存在显著的种族与社会经济差异。
  • 有证据表明这些种族与社会经济差异在2004至2016年间可能扩大。
  • 研究结果应有助于卫生政策制定者制定策略,改善种族与社会经济弱势人群获得高容量医院服务的机会。

研究设计与样本

  • 查询国家癌症数据库,纳入2004至2015年新诊断的胶质母细胞瘤患者。
  • 排除未接受手术干预或在报告机构以外地点接受手术干预的患者。
  • 计算每家医院的年手术病例量,将≥90百分位定义为高容量医院。
  • 采用多变量逻辑回归识别在高容量医院接受手术的患者层面预测因素。
  • 进行多项亚组分析,比较2016年与2004年各患者亚组在高容量医院接受手术的校正比值比。

主要发现

  • 共纳入51,859例患者,其中10.7%(n=5562)在高容量医院接受手术。
  • 西班牙裔白人患者在高容量医院手术的比值显著低于非西班牙裔白人(OR 0.58,95% CI 0.49-0.69,p < 0.001)。
  • 农村居民患者在高容量医院手术的比值显著低于都市居民(OR 0.55,95% CI 0.41-0.72,p < 0.001)。
  • 较低收入患者在高容量医院手术的比值显著更低:$50,354-$63,332(OR 0.68,95% CI 0.63-0.74,p < 0.001)、$40,227-$50,353(OR 0.84,95% CI 0.76-0.92,p < 0.001),参照组为≥$63,333。

关键数值与推荐

  • 高容量医院定义为年手术病例量≥90百分位。
  • 西班牙裔白人(参照非西班牙裔白人)在高容量医院手术的OR为0.58(95% CI 0.49-0.69,p < 0.001)。
  • 农村居民(参照都市居民)在高容量医院手术的OR为0.55(95% CI 0.41-0.72,p < 0.001)。
  • 无保险患者(参照私人保险)在高容量医院手术的OR为0.61(95% CI 0.51-0.72,p < 0.001)。
  • 收入$50,354-$63,332组(参照≥$63,333)在高容量医院手术的OR为0.68(95% CI 0.63-0.74,p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although it has been shown that surgery for glioblastoma (GBM) at high-volume facilities (HVFs) may be associated with better postoperative outcomes, the use of such hospitals may not be equally distributed. The authors aimed to evaluate racial and socioeconomic differences in access to surgery for GBM at high-volume Commission on Cancer (CoC)-accredited hospitals. METHODS: The National Cancer Database was queried for patients with GBM that was newly diagnosed between 2004 and 2015. Patients who received no surgical intervention or those who received surgical intervention at a site other than the reporting facility were excluded. Annual surgical case volume was calculated for each hospital, with volume ≥ 90th percentile defined as an HVF. Multivariable logistic regression was performed to identify patient-level predictors for undergoing surgery at an HVF. Furthermore, multiple subgroup analyses were performed to determine the adjusted odds ratio of the likelihood of undergoing surgery at an HVF in 2016 as compared to 2004 for each patient subpopulation (by age, race, sex, educational group, etc.). RESULTS: A total of 51,859 patients were included, with 10.7% (n = 5562) undergoing surgery at an HVF. On multivariable analysis, Hispanic White patients (OR 0.58, 95% CI 0.49-0.69, p < 0.001) were found to have significantly lower odds of undergoing surgery at an HVF (reference = non-Hispanic White). In addition, patients from a rural residential location (OR 0.55, 95% CI 0.41-0.72, p < 0.001; reference = metropolitan); patients with nonprivate insurance status (Medicare [OR 0.78, 95% CI 0.71-0.86, p < 0.001], Medicaid [OR 0.68, 95% CI 0.60-0.78, p < 0001], other government insurance [OR 0.68, 95% CI 0.52-0.86, p = 0.002], or who were uninsured [OR 0.61, 95% CI 0.51-0.72, p < 0.001]); and lower-income patients ($50,354-$63,332 [OR 0.68, 95% CI 0.63-0.74, p < 0.001], $40,227-$50,353 [OR 0.84, 95% CI 0.76-0.92, p < 0.001]; reference = ≥ $63,333) were also found to be significantly associated with a lower likelihood of surgery at an HVF. Subgroup analyses revealed that elderly patients (age ≥ 65 years), both male and female patients and non-Hispanic White patients, and those with private insurance, Medicare, metropolitan residential location, median zip code-level household income in the first and second quartiles, and educational attainment in the first and third quartiles had increased odds of undergoing surgery at an HVF in 2016 compared to 2004 (all p ≤ 0.05). On the other hand, patients with other governmental insurance, patients with a rural residence, and those from a non-White racial category did not show a significant difference in odds of surgery at an HVF over time (all p > 0.05). CONCLUSIONS: The present analysis from the National Cancer Database revealed significant disparities in access to surgery at an HVF for GBM within the United States. Furthermore, there was evidence that these racial and socioeconomic disparities may have widened between 2004 and 2016. The findings should assist health policy makers in the development of strategies for improving access to HVFs for racially and socioeconomically disadvantaged populations.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Goyal A, Zreik J, Brown DA, et al. Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer-accredited hospitals in the United States. J Neurosurg. 2021. PMID: 34767534. doi:10.3171/2021.7.JNS211307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。